CycloLab Cyclodextrin Research and Development Ltd. is a private SME with the focus on cyclodextrin research and development for over 30 years. CycloLab is working in the fields of pharmaceutical, cosmetic and food industry, agrochemical, environmental and analytical applications of cyclodextrins. CycloLab offers the widest variety of cyclodextrins in various grades for research, formulation studies, analytics, and cell cultures. They are primary manufacturers of Sulfobutylated Beta-Cyclodextrin Sodium Salt (Dexolve®) following strict cGMP conditions based on an FDA-approved Drug Master File. The company also operates as a CRO for cyclodextrin related services including development of product, offering custom synthesis of cyclodextrins, performing (sub) pilot-scale cGMP compliant manufacturing of cyclodextrins, and providing analytical services related to cyclodextrins. As an R&D company, CycloLab develops next generation proprietary cyclodextrins and explore potential applications as well. These are focused in several areas as evaluating cyclodextrins as excipients in new areas like protein stabilization and non-viral gene delivery, fermentation and enzymatic processes, serum free culture media, creating selective and targeted drug delivery systems and evaluation of cyclodextrins as API candidates for CNS diseases, infections and other conditions.